<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1180">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05145790</url>
  </required_header>
  <id_info>
    <org_study_id>8365</org_study_id>
    <nct_id>NCT05145790</nct_id>
  </id_info>
  <brief_title>The Place of Consultations Specializing in the Diagnosis of Mood Disorders in Strasbourg University Hospital</brief_title>
  <acronym>MOOD</acronym>
  <official_title>State of Play in Strasbourg University Hospital of the Place of Consultations Specializing in the Diagnosis of Mood Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mood disorders (depressive disorders and bipolar disorders) are among the ten most worrying&#xD;
      diseases of the 21st century according to the WHO.&#xD;
&#xD;
      In order to support psychiatrists in their diagnostic reflection, structures have been&#xD;
      created. Since 2009, the Psychiatry Service 2 within the Psychiatry, Mental Health and&#xD;
      Addictology Pole of the University Hospitals of Strasbourg has offered specialized&#xD;
      consultations in mood disorders.&#xD;
&#xD;
      More than 10 years after the creation of these consultations, it seems interesting to study&#xD;
      the profile of the users and to describe the nature of the reports of these in-depth&#xD;
      evaluation consultations (diagnosis, therapeutic advice)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2021</start_date>
  <completion_date type="Anticipated">March 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Descriptive study of the clinical characteristics of patients coming to consultations specializing in mood disorders in Strasbourg University Hospitals</measure>
    <time_frame>Files analysed retrospectively from January 01, 2018 to December 31, 2019 will be examined]</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">197</enrollment>
  <condition>Mood Disorders</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Major subject with pecialized primary consultation highlighting symptoms of mood disorders&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Major subject&#xD;
&#xD;
          -  Specialized primary consultation highlighting symptoms of mood disorders with Prof.&#xD;
             Berstchy in the psychiatry department 2 in the University Hospital of Strasbourg&#xD;
             (patients whose consultation request was linked to symptoms or a diagnosis of ADHD&#xD;
             will not be included in the study population).&#xD;
&#xD;
          -  Consultation that took place in 2018 and 2019.&#xD;
&#xD;
          -  Patient who did not express his opposition to the reuse of his data for scientific&#xD;
             research purposes.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patient opposition to the use of their personal data for scientific research purposes.&#xD;
&#xD;
          -  Prior existence of a previous specialist consultation in mood disorders with Prof.&#xD;
             Berstchy (the information collected during the first consultation is not accessible)&#xD;
&#xD;
          -  Patient under curatorship, guardianship or legal protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Gilles BERTSCHY, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de psychiatrie 2 - Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gilles BERTSCHY, MD, PhD</last_name>
    <phone>33 3 88 11 65 48</phone>
    <email>gilles.bertschy@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de psychiatrie 2 - Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles BERTSCHY, MD, PhD</last_name>
      <phone>33 3 88 11 65 48</phone>
      <email>gilles.bertschy@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Saïd CHAYER, PhD, HDR</last_name>
      <email>said.chayer@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Gilles BERTSCHY, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Léa SIMONIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 23, 2021</study_first_submitted>
  <study_first_submitted_qc>November 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2021</study_first_posted>
  <last_update_submitted>December 6, 2021</last_update_submitted>
  <last_update_submitted_qc>December 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mood Disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Mood Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

